Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
recombinant human growth hormone |
| gptkbp:activeIngredient |
gptkb:somatropin
|
| gptkbp:approvalYear |
2006
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:H01AC01
|
| gptkbp:bioequivalentTo |
gptkb:Genotropin
|
| gptkbp:contraindication |
active malignancy
acute critical illness |
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omnitrope
|
| gptkbp:indication |
gptkb:Prader-Willi_syndrome
gptkb:Turner_syndrome growth hormone deficiency |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sandoz
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
edema
headache joint pain injection site reaction |
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
biosimilar
|
| gptkbp:usedFor |
adults with growth hormone deficiency
children with growth failure |
| gptkbp:bfsParent |
gptkb:HGH
|
| gptkbp:bfsLayer |
6
|